APIS
|
Active Pharmaceutical Ingredient |
Latin Name |
Molecular Formula |
Defination |
Structural Formula |
|
Gentamycin Sulfate Injection |
Gentamycin Sulfate Iniectio |
C(19-21)H(39-43)N5O7·H2SO4 |
O-2-Amino-2,3,4,6,7-pentadeoxy-6-(methylamino)-a-D-ribo-heptopyranosyl-(1®4)-O-(3-deoxy-4-C-methyl-3-(methylamino)-b-L-arabinopyranosyl-(1®6))-2-deoxy-D-streptamine |
|
Product Specifications
|
Products |
Specification |
Vomume of vials |
Packing form |
|
Gentamycin Sulfate Injection |
BP latest version |
Colorless to slight yellow or slightly yellowish green, clarity liquid |
10amps/tray, 10trays/box |
Dosage
- Intramuscular injection or intravenous infusion after dilution for adults, 80mg (80,000 units) once, or 1-1.7mg/kg once per body weight, once every 8 hours; Or 5mg/kg once, once every 24 hours.
- Children intramuscular injection or diluted intravenous drip, once 2.5mg/kg, once every 12 hours; Or 1.7mg/kg once every 8 hours. The course of treatment is 7-14 days, during which blood concentration should be monitored as much as possible, especially in newborns or infants.
- The dosage of patients with renal dysfunction: according to normal renal function once every 8 hours, a normal dose of 1-1.7mg/kg, creatinine clearance rate of 10-50ml/min, once every 12 hours, a dose of 30-70% of the normal dose; When creatinine clearance is <10ml/min, 20-30% of the normal dose is given every 24-48 hours.



Adverse effect
Occasionally dizziness, insomnia, lethargy, nausea, diarrhea, constipation, rash, muscle pain and other symptoms. Arrhythmia, elevation of transaminase, changes of renal function, granulocytopenia, etc. may occur when large doses are used.



Matters need attention
It may cause hearing loss, tinnitus or ear fullness and other ototoxic reactions, affecting vestibular function can occur instability, vertigo. Nephrotoxic reactions such as hematuria, significantly reduced frequency of urination or decreased urine volume, decreased appetite, and extreme thirst may also occur. Low incidence of neuromuscular block or renal toxicity caused by dyspnea, lethargy, weakness and so on. Occasionally, skin rash, nausea, vomiting, hypohepatic function, leukopenia, granulocytopenia, anemia, hypotension, etc. Hearing loss, tinnitus or ear fullness and other ototoxic symptoms may occur in a small number of patients after stopping the drug, which should be noticed. Systemic administration combined with intrathecal injection may cause leg convulsions, rash, fever and general convulsions.
Hot Tags: gentamycin sulfate injection, China gentamycin sulfate injection manufacturers, suppliers, factory, Phenoxymethylpenicillin Potassium For Oral Suspension, , Benzathine Penicillin For Injection, lyophilized powder for injection, Ketoprofen For Injection, Vitamin B12 Injection









